LAVA Therapeutics NV (LAVA Therapeutics NV) Accounts Payable & Accrued Expense : $8.74 Mil (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is LAVA Therapeutics NV Accounts Payable & Accrued Expense?

LAVA Therapeutics NV's quarterly accounts payable & accrued expense declined from Jun. 2023 ($16.70 Mil) to Sep. 2023 ($15.23 Mil) and declined from Sep. 2023 ($15.23 Mil) to Dec. 2023 ($8.74 Mil).

LAVA Therapeutics NV's annual accounts payable & accrued expense increased from Dec. 2021 ($4.12 Mil) to Dec. 2022 ($11.80 Mil) but then declined from Dec. 2022 ($11.80 Mil) to Dec. 2023 ($8.74 Mil).

LAVA Therapeutics NV Accounts Payable & Accrued Expense Historical Data

The historical data trend for LAVA Therapeutics NV's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LAVA Therapeutics NV Accounts Payable & Accrued Expense Chart

LAVA Therapeutics NV Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

1.17

2.20

4.12

11.80

8.74

LAVA Therapeutics NV Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial												11.80	13.19	16.70	15.23	8.74

LAVA Therapeutics NV Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

LAVA Therapeutics NV (LAVA Therapeutics NV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » LAVA Therapeutics NV (NAS:LVTX) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

4PKB:Germany

Address

Yalelaan 62, Utrecht, UT, NLD, 3584 CM

Website

https://www.lavatherapeutics.com

LAVA Therapeutics NV is a biotechnology company. It is focused on transforming cancer treatment by developing a platform of novel bispecific antibodies designed to selectively induce gamma-delta T cell-mediated immunity against tumor cells.